Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Ecotoxicol Environ Saf ; 211: 111812, 2021 Mar 15.
Artigo em Inglês | MEDLINE | ID: mdl-33472112

RESUMO

Due to the potential hazard of diclofenac on aquatic organisms and the lack of higher-tier ecotoxicological studies, a long-term freshwater mesocosm experiment was set up to study the effects of this substance on primary producers and consumers at environmentally realistic nominal concentrations 0.1, 1 and 10 µg/L (average effective concentrations 0.041, 0.44 and 3.82 µg/L). During the six-month exposure period, the biovolume of two macrophyte species (Nasturtium officinale and Callitriche platycarpa) significantly decreased at the highest treatment level. Subsequently, a decrease in dissolved oxygen levels was observed. High mortality rates, effects on immunity, and high genotoxicity were found for encaged zebra mussels (Dreissena polymorpha) in all treatments. In the highest treatment level, one month after the beginning of the exposure, mortality of adult fish (Gasterosteus aculeatus) caused effects on the final population structure. Total abundance of fish and the percentage of juveniles decreased whereas the percentage of adults increased. This led to an overall shift in the length frequency distribution of the F1 generation compared to the control. Consequently, indirect effects on the community structure of zooplankton and macroinvertebrates were observed in the highest treatment level. The No Observed Effect Concentration (NOEC) value at the individual level was < 0.1 µg/L and 1 µg/L at the population and community levels. Our study showed that in more natural conditions, diclofenac could cause more severe effects compared to those observed in laboratory conditions. The use of our results for regulatory matters is also discussed.


Assuntos
Organismos Aquáticos/fisiologia , Diclofenaco/toxicidade , Poluentes Químicos da Água/toxicidade , Animais , Dreissena/efeitos dos fármacos , Peixes , Água Doce/química , Espécies Sentinelas , Smegmamorpha , Zooplâncton/efeitos dos fármacos
2.
Environ Int ; 189: 108728, 2024 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-38850672

RESUMO

Bisphenol A alternatives are manufactured as potentially less harmful substitutes of bisphenol A (BPA) that offer similar functionality. These alternatives are already in the market, entering the environment and thus raising ecological concerns. However, it can be expected that levels of BPA alternatives will dominate in the future, they are limited information on their environmental safety. The EU PARC project highlights BPA alternatives as priority chemicals and consolidates information on BPA alternatives, with a focus on environmental relevance and on the identification of the research gaps. The review highlighted aspects and future perspectives. In brief, an extension of environmental monitoring is crucial, extending it to cover BPA alternatives to track their levels and facilitate the timely implementation of mitigation measures. The biological activity has been studied for BPA alternatives, but in a non-systematic way and prioritized a limited number of chemicals. For several BPA alternatives, the data has already provided substantial evidence regarding their potential harm to the environment. We stress the importance of conducting more comprehensive assessments that go beyond the traditional reproductive studies and focus on overlooked relevant endpoints. Future research should also consider mixture effects, realistic environmental concentrations, and the long-term consequences on biota and ecosystems.


Assuntos
Compostos Benzidrílicos , Monitoramento Ambiental , Poluentes Ambientais , Fenóis , Fenóis/toxicidade , Compostos Benzidrílicos/toxicidade , Poluentes Ambientais/toxicidade , Monitoramento Ambiental/métodos , Animais , Humanos , Disruptores Endócrinos/toxicidade
3.
Toxicol Lett ; 235(2): 96-106, 2015 Jun 01.
Artigo em Inglês | MEDLINE | ID: mdl-25827406

RESUMO

The ban of animal testing has enhanced the development of new in vitro technologies for cosmetics safety assessment. Impedance metrics is one such technology which enables monitoring of cell viability in real time. However, analyzing real time data requires moving from static to dynamic toxicity assessment. In the present study, we built mechanistic biokinetic/toxicodynamic (BK/TD) models to analyze the time course of cell viability in cytotoxicity assay using impedance. These models account for the fate of the tested compounds during the assay. BK/TD models were applied to analyze HepaRG cell viability, after single (48 h) and repeated (4 weeks) exposures to three hepatotoxic compounds (coumarin, isoeugenol and benzophenone-2). The BK/TD models properly fit the data used for their calibration that was obtained for single or repeated exposure. Only for one out of the three compounds, the models calibrated with a single exposure were able to predict repeated exposure data. We therefore recommend the use of long-term exposure in vitro data in order to adequately account for chronic hepatotoxic effects. The models we propose here are capable of being coupled with human biokinetic models in order to relate dose exposure and human hepatotoxicity.


Assuntos
Alternativas aos Testes com Animais , Doença Hepática Induzida por Substâncias e Drogas/etiologia , Cosméticos/farmacocinética , Cosméticos/toxicidade , Modelos Biológicos , Testes de Toxicidade/métodos , Animais , Benzofenonas/farmacocinética , Benzofenonas/toxicidade , Sobrevivência Celular/efeitos dos fármacos , Cumarínicos/farmacocinética , Cumarínicos/toxicidade , Relação Dose-Resposta a Droga , Impedância Elétrica , Eugenol/análogos & derivados , Eugenol/farmacocinética , Eugenol/toxicidade , Células Hep G2 , Humanos , Cinética , Modelos Lineares , Reprodutibilidade dos Testes , Medição de Risco , Toxicocinética
4.
J Health Care Poor Underserved ; 12(3): 290-301, 2001 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-11475547

RESUMO

Lack of follow-up care for hypertension adversely affects health in urban communities. The authors designed this study to (1) evaluate the effectiveness of a specialized intervention program for hypertension follow-up and (2) evaluate the associations with loss to follow-up. They evaluated factors related to loss to follow-up to either a routine care medical clinic or a special primary care intervention program (the Competitive Initiative Program [CIP]). They also conducted interviews to provide in-depth information on the barriers to this program. They found that patients referred through the CIP were significantly more likely to receive follow-up care through a primary care provider. Cost of care, long waiting times, lack of physician continuity, and more pressing priorities explained the lack of follow-up care. Despite a program to provide health care at no cost to patients, lack of insurance and worries about cost are described as barriers to adequate follow-up for hypertension treatment.


Assuntos
Continuidade da Assistência ao Paciente , Acessibilidade aos Serviços de Saúde , Hipertensão/terapia , Serviço Hospitalar de Emergência , Feminino , Seguimentos , Custos de Cuidados de Saúde , Humanos , Masculino , Pessoa de Meia-Idade , New Jersey , População Urbana
5.
SAR QSAR Environ Res ; 25(5): 407-21, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-24874994

RESUMO

The circulating endogenous steroids are transported in the bloodstream. These are bound to a highly specific sex hormone-binding globulin (SHBG) and in lower affinity to proteins such as the corticosteroid-binding protein and albumin in vertebrates, including fish. It is generally believed that the glycoprotein SHBG protects these steroids from rapid metabolic degradation and thus intervenes in its availability at the target tissues. Endocrine disrupters binding to SHBG affect the normal activity of natural steroids. Since xenobiotics are primarily released in the aquatic environment, there is a need to evaluate the binding affinity of xenosteroid mimics on fish SHBG, especially in zebrafish (Danio rerio), a small freshwater fish originating in India and widely employed in ecotoxicology, toxicology, and genetics. In this context, a zebrafish SHBG (zfSHBG) homology model was developed using the human SHBG (hSHBG) receptor structure as template. It was shown that interactions with amino acids Ser-36, Asp-59 and Thr-54 were important for binding affinity. A ligand-based pharmacophore model was also developed for both zfSHBG and hSHBG inhibitors that differentiated binders from non-binders, but also demonstrated structural requirements for zfSHBG and hSHBG ligands. The study provides insights into the mechanism of action of endocrine disruptors in zebrafish as well as providing a useful tool for identifying anthropogenic compounds inhibiting zfSHBG.


Assuntos
Disruptores Endócrinos/toxicidade , Relação Quantitativa Estrutura-Atividade , Globulina de Ligação a Hormônio Sexual/metabolismo , Poluentes Químicos da Água/toxicidade , Xenobióticos/metabolismo , Animais , Disruptores Endócrinos/química , Disruptores Endócrinos/metabolismo , Simulação de Acoplamento Molecular , Poluentes Químicos da Água/química , Poluentes Químicos da Água/metabolismo , Xenobióticos/toxicidade , Peixe-Zebra
6.
Antimicrob Agents Chemother ; 37(6): 1264-9, 1993 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-7687121

RESUMO

Bleomycin induces strand breakage in DNA through disruption of glycosidic linkages. We investigated the ability of bleomycin to damage yeast cell walls, which are composed primarily of carbohydrate. Bleomycin treatment of intact yeast cells facilitated enzymatic conversion of yeasts to spheroplasts. Bleomycin treatment also altered anchorage of mannoproteins to the cell wall matrix in intact cells or isolated cell walls. Cell surface mannoproteins were labelled with 125I, and their solubilization was monitored. Seventeen hour treatments with bleomycin released some of the label directly into treatment supernatants and facilitated extraction of mannoproteins by dithiothreitol and lytic enzymes. Bleomycin treatments as short as 10 min caused changes in extraction of mannoproteins from intact cells. Specifically, cell wall anchorage of several mannoproteins was affected by the drug. There were drug-induced changes in extractability of mannoproteins with apparent molecular weights of 96,000, 80,000, 61,000, 41,000, 31,500, and 21,000 (determined after deglycosylation with endo-N-acetylglucosaminidase H). The similarity of results obtained in the presence and absence of cycloheximide, the appearance of cell wall effects after only 10 min of treatment, and the similarity of effects in intact cells and isolated cell walls are consistent with direct drug-induced damage and inconsistent with a mechanism dependent on expression of bleomycin-damaged genes or other intracellular mediators. The results are consistent with bleomycin-mediated increases in cell wall permeability through disruption of glycosidic cross-linking structures in the cell wall.


Assuntos
Bleomicina/farmacologia , Glicoproteínas de Membrana/efeitos dos fármacos , Glicoproteínas de Membrana/metabolismo , Saccharomyces cerevisiae/efeitos dos fármacos , Adesão Celular/efeitos dos fármacos , Adesão Celular/fisiologia , Parede Celular/efeitos dos fármacos , Parede Celular/fisiologia , Proteínas Fúngicas/metabolismo , Saccharomyces cerevisiae/ultraestrutura , Esferoplastos/efeitos dos fármacos , Esferoplastos/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA